JP2004536824A5 - - Google Patents

Download PDF

Info

Publication number
JP2004536824A5
JP2004536824A5 JP2003506430A JP2003506430A JP2004536824A5 JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5 JP 2003506430 A JP2003506430 A JP 2003506430A JP 2003506430 A JP2003506430 A JP 2003506430A JP 2004536824 A5 JP2004536824 A5 JP 2004536824A5
Authority
JP
Japan
Prior art keywords
monoclonal antibody
seq
chimeric monoclonal
acid sequence
organism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003506430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536824A (ja
Filing date
Publication date
Priority claimed from US09/881,823 external-priority patent/US20020068066A1/en
Application filed filed Critical
Publication of JP2004536824A publication Critical patent/JP2004536824A/ja
Publication of JP2004536824A5 publication Critical patent/JP2004536824A5/ja
Pending legal-status Critical Current

Links

JP2003506430A 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子 Pending JP2004536824A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/881,823 US20020068066A1 (en) 1999-08-20 2001-06-15 Method for the treatment and prevention of dental caries
PCT/US2002/018692 WO2002102975A2 (en) 2001-06-15 2002-06-11 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans

Publications (2)

Publication Number Publication Date
JP2004536824A JP2004536824A (ja) 2004-12-09
JP2004536824A5 true JP2004536824A5 (https=) 2005-09-22

Family

ID=25379292

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003506430A Pending JP2004536824A (ja) 2001-06-15 2002-06-11 Ｓ．ｍｕｔａｎｓに対するヒト化モノクローナル抗体を作製するためのＤＮＡ分子および組換えＤＮＡ分子

Country Status (6)

Country Link
US (1) US20020068066A1 (https=)
EP (1) EP1434799A4 (https=)
JP (1) JP2004536824A (https=)
AU (1) AU2002318342A2 (https=)
CA (1) CA2448506A1 (https=)
WO (1) WO2002102975A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
US7846895B2 (en) 2006-09-06 2010-12-07 The Regents Of The University Of California Selectively targeted antimicrobial peptides and the use thereof
WO2008140834A2 (en) * 2007-01-16 2008-11-20 The Regents Of The University Of California Novel antimicrobial peptides
CN103037900B (zh) 2010-02-24 2016-04-06 伊缪诺金公司 叶酸受体1抗体与免疫缀合物以及其用途
AU2014203172B2 (en) * 2010-02-24 2016-03-10 Immunogen, Inc. Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
CL2011003002A1 (es) * 2011-11-25 2012-05-25 Univ Pontificia Catolica Chile Anticuerpo monoclonal o un fragmento del mismo que se une a la proteina m2-1 del virus respiratorio sincicial (vrs) humano; secuencias nucleotidicas; composicion farmaceutica; metodo de diagnostico de infeccion producida por vrs; kit; y uso de dicho anticuerpo para preparar un medicamento.
WO2016049183A1 (en) * 2014-09-24 2016-03-31 Aerpio Therapeutics, Inc. Ve-ptp extracellular domain antibodies delivered by a gene therapy vector
AU2017299581B2 (en) * 2016-07-20 2024-05-23 EyePoint, Inc. Humanized monoclonal antibodies that target ve-ptp (hptp-β)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) * 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
EP1400536A1 (en) * 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
WO2000011037A1 (en) * 1998-08-21 2000-03-02 The Regents Of The University Of California Monoclonal antibodies specific for streptococcus mutans, and uses thereof
EP1313506A1 (en) * 2000-08-24 2003-05-28 Washington Dental Service Immunologic method for the prevention of dental caries

Similar Documents

Publication Publication Date Title
JP2022105178A (ja) 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓ ａｕｒｅｕｓ）感染症を治療および予防するための組成物および方法
RU2757813C2 (ru) Антитело против lag-3, его антигенсвязывающий фрагмент и их фармацевтическое применение
JP2919071B2 (ja) 癌および感染症にたいするワクチン
CN111683966B (zh) 与cd22结合的重链抗体
TWI843799B (zh) 抗pd-1抗體、其抗原結合片段及醫藥用途
CN104640878B (zh) 交叉反应的金黄色葡萄球菌抗体
US20130267688A1 (en) Novel antibody structures derived from human germline sequences
JP2018510636A5 (https=)
RU2009128064A (ru) Антитела к cd44
WO2019091449A1 (zh) Cd96抗体、其抗原结合片段及医药用途
KR20200012920A (ko) 항-cd40 항체, 이의 항원 결합 단편 및 이의 의학적 용도
WO2022105914A1 (zh) Cd70抗体及其应用
MY137078A (en) Recombinant antibodies associated to gangliosides. their use indiagnosis and treatment of tumors.
CN112513088A (zh) 抗ox40抗体、其抗原结合片段及其医药用途
CN109867723B (zh) 抗人il6单克隆抗体及其制备方法和用途
JP2004536824A5 (https=)
JP2009524428A5 (https=)
CN114829395A (zh) 抗angptl3抗体及其应用
CZ20013673A3 (cs) Anti-idiotypová protilátka k protilátce inhibující vazbu imunglobulínu E na jeho receptor s vysokou afinitou a farmaceutický přípravek obsahující takovou protilátku
JP2018509147A (ja) 抗スクレロスチン抗体、その抗原結合フラグメントおよびその医薬用途
JP2003521219A5 (https=)
KR20120016086A (ko) 슈도모나스 애루지노사 혈청형 ｉａｔｓ ０１의 지질다당류(ｌｐｓ) 특이적 인간 단일클론 항체
CA2525657A1 (en) Human monoclonal antibody specific for lipopolysaccharides (lps) of serotype iats o6 of pseudomonas aeruginosa
US20240059764A1 (en) ANTIGEN-BINDING PROTEIN TARGETING STAPHYLOCOCCUS AUREUS a-HEMOLYSIS AND APPLICATION THEREOF
JP2011511625A5 (https=)